“Die Unberechenbaren (The Incalculable Ones)”
In an article in the July 2, 2009 issue of Financial Times Deutschland about rising prices for new medications, Booz & Company Partner Rolf Fricker (Germany) said that the costs for pharmaceutical companies can be significant. “Research and development are (not) cheap,” said Fricker in remarks taken from a recent speech. “Costs between $600 million and $ 800 million (U.S.) have to be estimated to fully develop a drug for the market, including failures.” Even then, the odds are slim that the drug will ever get to market. “Only one of 500 candidates makes its way to the sales,” added Fricker.